Our products

Addressing unmet patient needs in oncology

Our medicine is approved in individual countries for specific uses and the information we provide for patients is governed by local regulations. Product availability, name and indication may vary by country. Always ask a healthcare professional for advice about medicines.

To report negative side effects of prescription drugs to the FDA, visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).


KIMMTRAK (tebentafusp-tebn)
(Injection for Intravenous Use 100 mcg/0.5 mL)


KIMMTRAK (tebentafusp)
(Concentrate for Solution for Infusion 200 mcg/mL)


KIMMTRAK (tebentafusp)
(Concentrate for Solution for Infusion 100 mcg/0.5 mL)